inflammatory bowel disease: A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
361 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
361 |
6. Filter based on genotype QC (FinnGen only) |
361 |
Control definitions (FinnGen only)
- Control exclude
- K11_IBD, K11_CHOLANGI
- Control conditions
- not K11_CHOLANGI_STRICT
and not K11_IBD_STRICT
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
IBD (strict) with PSC
based on the number of shared cases.
Similar with more cases:
- Cholangitis (primary sclerosing, PSC), with reimbursement 202
- Cholangitis (primary sclerosing, PSC)
- IBD patients in KELA-register
- Inflammatory bowel disease, strict (require KELA)
- Inflammatory bowel disease
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1111 | 437 | 667 |
| Only index persons | 1084 | 428 | 656 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 25.72 | 27.13 | 24.52 |
| Only index persons | 25.50 | 27.02 | 24.51 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 361 | 169 | 192 |
| Unadjusted period prevalence (%) | 0.07 | 0.06 | 0.08 |
| Median age at first event (years) | 25.83 | 26.63 | 25.12 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 330
- Matched controls
- 3299
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A05AA02
ATC
ursodeoxycholic acid; oral
4927.8
323.0
320
17
K83.0
ICD-10 Finland
Cholangitis
+∞
323.0
330
*
A07EC02
ATC
mesalazine; oral, rectal
5259.0
323.0
315
10
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
323.0
330
156
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
323.0
330
*
K51.5
ICD-10 Finland
Left sided colitis
11435.2
314.8
251
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
1698.8
305.7
251
6
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3302.5
267.6
222
*
UJF30
NOMESCO Finland
Ileoscopy through colon
64.0
189.5
226
108
UJF32
NOMESCO Finland
Coloscopy
46.4
183.9
273
308
L04AX01
ATC
azathioprine; systemic
125.0
142.7
147
21
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
178.7
138.0
137
13
K51.8
ICD-10 Finland
Other ulcerative colitis
+∞
134.9
120
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
304.3
123.0
118
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
28.0
119.3
174
126
A07EA06
ATC
budesonide; oral, local oral
165.8
117.3
118
11
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
116.8
105
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
73.0
116.2
130
29
UJK02
NOMESCO Finland
ERCP
101.0
114.6
122
19
WX404
NOMESCO Finland
Intravenous generell anesthesy
16.3
109.5
225
383
K50.8
ICD-10 Finland
Other Crohn disease
+∞
92.1
84
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
1136.3
91.3
85
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
143.0
90.5
93
9
WX402
NOMESCO Finland
General anaesthesia
12.4
83.5
181
295
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
10.3
78.3
201
434
K50.1
ICD-10 Finland
Crohn disease of large intestine
+∞
77.2
71
*
UJK12
NOMESCO Finland
Peroral cholangioscopy
897.4
75.3
71
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
464.9
74.9
72
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
69.9
74.5
84
16
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
71.5
66
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
70.4
65
*
ZXE00
NOMESCO Finland
One hour or less
8.5
68.7
242
807
P01AB01
ATC
metronidazole; oral, rectal
7.8
64.0
234
789
A07EA02
ATC
hydrocortisone; rectal
253.4
62.5
62
*
ZXD10
NOMESCO Finland
Scheduled procedure
6.8
56.6
215
715
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.4
55.9
168
404
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
625.5
55.2
53
*
Z2221
NOMESCO Finland
Medical doctor
6.5
52.5
186
547
K50.0
ICD-10 Finland
Crohn disease of small intestine
+∞
51.4
48
*
H02AB06
ATC
prednisolone; systemic
5.8
48.2
229
927
J01MA12
ATC
levofloxacin; systemic
7.3
46.6
131
272
K83.1
ICD-10 Finland
Obstruction of bile duct
114.7
46.2
49
5
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.1
43.8
111
195
ZX120
NOMESCO Finland
Intravenous
10.0
41.9
90
119
WX002
NOMESCO Finland
Sedation and analgesia
6.6
41.7
127
287
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
+∞
41.5
39
*
H02AB07
ATC
prednisone; oral
8.0
40.3
101
172
TPH04
NOMESCO Finland
Cathetrisation of vein
6.0
40.1
134
338
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
155.5
39.7
41
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
39.4
37
*
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
96.0
38.8
42
5
J01MA02
ATC
ciprofloxacin; systemic
4.8
38.3
180
658
A07EC01
ATC
sulfasalazine; oral, rectal
9.3
37.3
83
115
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
37.2
35
*
K51
ICD-10 Finland
Ulcerative colitis
398.7
36.7
36
*
Z94.4
ICD-10 Finland
Liver transplant status
142.6
36.5
38
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
12.7
36.2
67
65
K76.9
ICD-10 Finland
Liver disease, unspecified
42.0
35.7
44
12
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
35.0
33
*
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
35.0
33
*
L01BB02
ATC
mercaptopurine; oral
195.0
34.4
35
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
62.9
34.1
39
7
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
188.8
33.4
34
*
K74.3
ICD-10 Finland
Primary biliary cirrhosis
77.9
31.6
35
5
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
176.5
31.3
32
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
91.5
30.3
33
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
10.4
30.1
61
70
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
41.4
30.0
37
10
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
113.7
29.2
31
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
28.6
27
*
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
27.5
26
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
27.5
26
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
293.7
27.1
27
*
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
281.5
26.1
26
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
146.5
26.0
27
*
L04AD01
ATC
ciclosporin; systemic
22.3
24.9
36
18
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
+∞
24.3
23
*
127
Kela drug reimbursment
Transplant complication
19.8
22.7
34
19
C10AC01
ATC
colestyramine; oral
27.3
22.2
30
12
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
21.9
159
734
L04AB04
ATC
adalimumab; parenteral
20.7
21.7
32
17
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
25.2
21.7
30
13
JJ5AT
NOMESCO Finland
NA
+∞
21.1
20
*
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
21.1
20
*
A07EA01
ATC
prednisolone; rectal
+∞
21.1
20
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
61.6
20.2
23
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
7.9
20.0
47
68
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
16.0
19.8
32
22
H02AB04
ATC
methylprednisolone; systemic
4.5
19.7
76
204
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.0
19.3
66
156
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
13.4
19.1
33
27
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
18.9
18
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
200.9
18.7
19
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.3
18.6
39
47
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
15.6
18.5
30
21
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.5
18.4
71
190
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
9.8
18.2
37
42
L04AC05
ATC
ustekinumab; parenteral
+∞
17.9
17
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
30.8
17.7
23
8
JN4CD
NOMESCO Finland
Very extensive body CT
11.7
17.4
32
30
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
53.0
17.2
20
*
L04AA06
ATC
mycophenolic acid; systemic
13.7
17.0
29
23
3AC01
NOMESCO Finland
NA
29.3
16.7
22
8
D94
ICPC
Chronic enteritis/ulcerative colitis
178.7
16.7
17
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
10.1
16.6
33
36
UJF92
NOMESCO Finland
Capsular endoscopy
15.6
16.1
26
18
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
16.1
148
753
N02AX02
ATC
tramadol; systemic, rectal
2.7
16.0
155
814
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
63.2
15.9
18
*
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
15.7
15
*
K85.8
ICD-10 Finland
Other acute pancreatitis
40.2
15.6
19
5
JN3AD
NOMESCO Finland
Abdominal CT examination
6.0
15.3
43
80
UJF02
NOMESCO Finland
Peroral enteroscopy
59.5
14.9
17
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
19.5
14.9
22
12
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
+∞
14.7
14
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
14.6
115
526
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
37.9
14.6
18
5
WX419
NOMESCO Finland
Other general anesthesy
28.7
14.4
19
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.4
14.3
38
66
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
55.8
13.9
16
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.1
13.5
33
51
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
13.0
44
102
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
52.2
12.9
15
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
21.1
12.6
18
9
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
+∞
12.6
12
*
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
12.3
12.5
22
19
R50.9
ICD-10 Finland
Fever, unspecified
3.2
12.3
71
258
TK800
NOMESCO Finland
Hemodialysis
11.7
12.2
22
20
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
11.7
12.2
22
20
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
48.5
12.0
14
*
R4110
NOMESCO Finland
Physiotherapy
2.6
11.9
101
473
Z3226
NOMESCO Finland
Physiotherapist
3.1
11.9
73
279
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.0
11.7
74
290
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
+∞
11.5
11
*
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
124.2
11.5
12
*
WVA20
NOMESCO Finland
Medicine administration
9.7
11.2
22
24
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
44.9
11.0
13
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.5
11.0
19
16
ZXE40
NOMESCO Finland
More than seven and less than nine hours
9.3
10.9
22
25
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
11.8
10.7
19
17
4AA12
NOMESCO Finland
NA
62.1
10.7
12
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
10.6
10.7
20
20
A07DA03
ATC
loperamide; oral
8.6
10.5
22
27
K83.3
ICD-10 Finland
Fistula of bile duct
+∞
10.5
10
*
JFF10
NOMESCO Finland
Loop enterostomy
+∞
10.5
10
*
Z93.2
ICD-10 Finland
Ileostomy status
+∞
10.5
10
*
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
16.7
10.5
16
10
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.8
10.2
25
39
A02BC02
ATC
pantoprazole; systemic
2.1
10.2
198
1359
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
41.4
10.0
12
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.2
9.9
30
62
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.7
9.9
33
76
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
9.6
77
345
K92.1
ICD-10 Finland
Melaena
5.7
9.6
27
51
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
22.5
9.4
13
6
K83
ICD-10 Finland
Other diseases of biliary tract
+∞
9.4
9
*
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
+∞
9.4
9
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
9.2
30
67
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
5.2
9.2
28
58
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.9
9.1
22
34
Z2446
NOMESCO Finland
Social worker
3.8
9.0
38
109
JAH00
NOMESCO Finland
Laparotomy
9.9
8.9
17
18
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
92.3
8.5
9
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
92.3
8.5
9
*
K85
ICD-10 Finland
Acute pancreatitis
9.8
8.4
16
17
K83.4
ICD-10 Finland
Spasm of sphincter of Oddi
+∞
8.4
8
*
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
+∞
8.4
8
*
JJA20
NOMESCO Finland
Open biopsy of liver
+∞
8.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.8
8.3
35
101
H02AB09
ATC
hydrocortisone; systemic
7.1
8.2
19
28
A02BC01
ATC
omeprazole; systemic
2.3
8.1
85
433
L04AA01
ATC
[U] ciclosporin; systemic
9.3
8.1
16
18
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
17.7
8.1
12
7
4AB02
NOMESCO Finland
NA
34.3
8.1
10
*
A07AA09
ATC
vancomycin; oral
22.7
8.1
11
5
1370
FHL
Colonoscopy, whole colon
22.7
8.1
11
5
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
22.7
8.1
11
5
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
8.0
49
184
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
7.9
113
660
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
46.1
7.7
9
*
WX004
NOMESCO Finland
Patient-controlled sedation
18.9
7.6
11
6
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
5.1
7.6
23
48
XPX08
NOMESCO Finland
Intraoperative flow measurement
81.9
7.4
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
81.9
7.4
8
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
81.9
7.4
8
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
81.9
7.4
8
*
R94.5
ICD-10 Finland
Abnormal results of liver function studies
9.7
7.4
14
15
B01AB05
ATC
enoxaparin; parenteral
2.2
7.4
82
429
1280
FHL
Endoscopic retrograde cholangiography and pancreaticography
+∞
7.3
7
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
7.3
7
*
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
7.3
7
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
7.3
7
*
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.8
7.3
30
85
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.2
7.2
15
19
J04AB02
ATC
rifampicin; systemic
30.7
7.2
9
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
6.3
7.2
18
30
M81.9
ICD-10 Finland
Osteoporosis, unspecified
9.1
7.1
14
16
D64.9
ICD-10 Finland
Anaemia, unspecified
3.6
6.9
30
89
ZXD05
NOMESCO Finland
Urgent procedure
2.0
6.8
107
641
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
40.9
6.8
8
*
M81.8
ICD-10 Finland
Other osteoporosis
40.9
6.8
8
*
JKA20
NOMESCO Finland
Cholecystectomy
8.1
6.7
14
18
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.1
6.7
37
130
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.9
6.7
26
71
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
12.6
6.6
11
9
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
71.2
6.4
7
*
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
8.4
6.4
13
16
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.9
6.3
38
144
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
6.3
33
114
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
+∞
6.3
6
*
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
6.3
6
*
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
+∞
6.3
6
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
+∞
6.3
6
*
4AA33
NOMESCO Finland
NA
+∞
6.3
6
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
6.3
52
236
JFF13
NOMESCO Finland
Terminal enterostomy
27.2
6.3
8
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
6.3
73
388
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
6.2
65
329
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
10.3
6.1
11
11
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
283
255
47.74
309.92
3.7
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
226
28
214.16
307.65
3.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
216
71
74.25
307.65
2.8
1.1
iu/ml
4.4
—
—
12
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
317
183
134.92
307.65
9.0
4.5
ug/l
2.4
33.0
0.68
252
145
(3007566) Smooth muscle Ab [Titer] in Serum
246
83
90.90
307.65
3.1
1.1
titre
64.8
68.3
—
27
6
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
291
66
223.23
307.65
8.4
2.9
u/ml
29.5
2136.2
0.51
272
57
(3024980) IgG subclass 4 [Mass/volume] in Serum
226
50
119.19
307.65
3.3
1.3
g/l
0.8
0.5
2.16
213
40
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
235
19
352.50
307.65
2.8
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
168
23
135.75
307.65
2.0
1.1
titre
179.0
—
—
10
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
166
14
218.66
307.65
1.9
1.4
umol/l
11.2
10.0
0.53
166
14
(3048689) Calprotectin [Mass/mass] in Stool
325
354
83.04
307.65
7.0
1.3
ug/g
188.7
70.7
9.38
309
271
(3005719) IgG [Mass/volume] in Serum or Plasma
265
216
43.37
304.61
4.6
2.3
g/l
12.9
10.0
16.06
259
200
(40768441) Liver Pathology biopsy report
113
17
96.30
213.41
2.4
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
238
303
21.12
200.98
12.1
2.2
umol/l
8.2
8.8
0.13
228
262
(3037522) Nuclear Ab [Titer] in Serum
261
396
21.18
194.74
3.3
1.4
titre
501.9
403.3
0.47
106
85
(3032080) INR in Blood by Coagulation assay
326
862
29.69
150.81
18.5
6.0
inr
1.0
1.1
2.46
106
268
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
339
993
40.61
141.80
17.7
3.1
u/l
36.4
31.6
2.64
334
948
(3042936) Bacteria identified in Isolate by Culture
206
341
12.74
136.67
2.7
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
128
123
15.57
123.93
2.7
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
302
869
16.15
122.53
14.9
5.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
261
647
11.95
120.27
3.8
1.4
g/l
2.6
2.3
2.65
251
413
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
88
48
23.92
114.39
7.6
5.9
iu/ml
762.2
721.0
—
21
7
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
169
281
10.43
108.65
3.2
2.4
%
21.4
24.7
1.81
155
248
(3044640) Blood type and Crossmatch panel - Blood
255
801
8.44
86.55
4.2
2.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
226
649
7.64
83.44
6.0
3.7
ph
7.4
7.4
1.61
45
112
(3006922) Hepatitis E virus Ab [Presence] in Serum
54
18
35.10
83.33
1.1
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
125
194
9.33
83.07
16.1
7.6
mmol/l
7.1
7.8
0.58
120
188
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
53
18
34.34
81.27
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
53
18
34.34
81.27
1.2
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
325
1368
14.80
80.11
18.6
5.9
e9/l
0.5
0.6
1.44
314
1206
(3006315) Basophils [#/volume] in Blood
325
1374
14.69
79.53
18.6
6.0
e9/l
0.0
0.0
0.34
314
1210
(3013115) Eosinophils [#/volume] in Blood
330
1423
16.36
79.05
18.7
6.4
e9/l
0.2
0.2
0.43
317
1272
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
193
499
7.16
78.60
4.8
1.9
mg/l
3.0
3.0
0.02
181
432
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
290
1111
9.19
77.55
11.0
7.0
mmol/l
1.2
1.2
0.53
262
962
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
52
20
30.21
76.48
4.6
2.2
%
90.8
96.1
0.29
52
20
(3019198) Lymphocytes [#/volume] in Blood
325
1438
13.64
73.65
18.7
5.9
e9/l
1.8
2.0
2.34
314
1290
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
271
1008
7.77
73.44
9.6
6.3
mmol/l
1.2
1.2
0.05
265
927
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
235
780
6.77
71.70
6.5
2.3
u/l
69.3
55.3
1.45
228
731
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
44
12
41.62
71.56
5.1
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
57
33
20.32
71.09
1.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
70
64
13.33
68.01
1.4
1.4
u/ml
482.0
163.9
3.52
38
35
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
71
69
12.56
66.27
1.4
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
330
1599
13.39
64.26
22.8
9.6
e9/l
3.5
4.0
7.71
323
1408
(3021589) Normoblasts [#/volume] in Blood
284
1228
7.15
61.18
25.9
8.4
e9/l
0.0
0.0
0.51
266
1001
(3023183) Ammonium ion [Moles/volume] in Plasma
61
53
13.65
60.97
6.7
3.2
umol/l
32.9
36.7
0.53
56
45
(40768804) Tissue Pathology biopsy report
258
1035
6.23
60.34
3.7
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
45
22
23.22
60.16
1.2
1.3
u/l
44.5
60.1
1.18
36
15
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
68
73
11.24
59.08
1.9
1.4
iu/ml
0.0
0.4
0.61
25
11
(4035726)
106
195
7.28
58.98
1.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
201
678
5.43
57.13
13.9
7.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
64
68
11.22
55.91
1.4
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
63
66
11.35
55.57
1.4
1.5
u/ml
119.3
102.0
—
10
8
(3017143) Hepatitis C virus Ab [Presence] in Serum
159
457
5.43
54.34
1.7
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
40
22
20.32
50.65
3.6
1.3
g/l
0.8
1.1
1.66
40
22
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
82
134
7.62
50.51
1.4
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
175
600
4.72
46.86
3.7
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
42
30
15.71
46.67
1.2
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
52
54
11.08
45.89
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
166
557
4.67
45.48
7.8
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
172
603
4.54
44.26
1.9
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
42
33
14.27
44.20
2.5
2.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
76
134
6.92
43.28
1.4
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
46
44
11.84
42.84
2.4
4.8
u/ml
1393.7
4958.0
—
6
5
(3001122) Ferritin [Mass/volume] in Serum or Plasma
254
1208
4.72
42.60
4.9
2.7
ug/l
88.2
101.9
0.89
249
1133
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
32
16
21.85
42.04
2.0
1.4
u/l
1.1
0.6
—
21
5
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
251
1218
4.48
40.06
6.5
3.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
36
27
14.70
38.78
1.1
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
47
10.52
37.89
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
214
5.27
37.03
3.1
2.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
41
7
65.76
36.02
1.2
4.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
82
191
5.26
34.40
5.4
5.6
%
0.3
0.5
0.48
21
51
(3017181) Myelocytes/100 leukocytes in Blood
86
209
5.09
34.32
6.2
5.7
%
0.5
0.9
0.97
30
71
(3025159) Blasts/100 leukocytes in Blood
79
183
5.25
33.29
6.3
6.1
%
0.0
0.0
0.49
22
53
(3021879) Hepatitis B virus core Ab [Presence] in Serum
100
281
4.54
33.28
1.5
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
34
31
12.00
32.46
1.3
1.3
g/l
0.5
0.3
1.14
23
22
(3027135) IgG subclass 1 [Mass/volume] in Serum
34
31
12.00
32.46
1.3
1.3
g/l
10.7
6.4
3.20
24
22
(3028192) IgG subclass 2 [Mass/volume] in Serum
34
31
12.00
32.46
1.3
1.3
g/l
3.5
2.8
0.74
23
22
(4062490)
34
31
12.00
32.46
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
302
1865
4.79
30.31
3.9
3.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
78
193
4.88
30.24
6.7
6.1
%
0.0
0.2
1.09
28
62
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
114
381
3.91
29.61
2.8
2.6
e6/l
2.7
2.4
0.11
74
197
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
81
6.84
29.27
1.3
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
34
9
41.47
27.62
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
34
9
41.47
27.62
1.0
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
166
736
3.32
27.42
3.8
2.8
e6/l
249.2
58.6
0.39
136
552
(40768797) Stomach Pathology biopsy report
104
343
3.85
27.32
1.6
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
154
659
3.33
26.88
3.9
2.7
e6/l
0.3
0.3
0.24
127
477
(36304419) Bacteria [Presence] in Urine
151
643
3.32
26.51
3.8
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
56
7.69
26.41
1.5
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
65
154
4.93
26.38
5.7
3.2
mmol/l
1.2
1.2
1.19
60
138
(3034274) Bile acid [Moles/volume] in Serum --fasting
40
60
7.37
26.06
3.4
2.5
umol/l
36.6
5.0
2.65
35
44
(3018095) Leukocytes [#/volume] in Urine
184
896
3.15
25.45
4.4
3.3
e6/l
16.9
65.7
1.31
142
587
(3002032) Base excess in Venous blood by calculation
76
211
4.30
25.22
5.6
5.5
mmol/l
0.9
1.5
0.76
67
168
(3000991) Gas panel - Venous blood
72
197
4.32
24.31
15.1
10.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
70
190
4.33
23.86
2.7
2.2
ml/min/173m2
65.7
77.0
0.70
26
73
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
177
869
3.03
23.71
2.4
1.7
pmol/l
93.3
97.0
0.58
113
457
(3026782) Osmolality of Urine
117
453
3.34
23.63
3.2
2.4
mosm/kgh2o
553.0
571.1
0.35
106
387
(3023520) Reticulocytes [#/volume] in Blood
60
149
4.63
22.87
2.7
3.7
e9/l
73.8
76.1
0.15
43
111
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
45
87
5.77
22.85
3.2
4.3
%
214.4
164.1
3.67
45
87
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
104
5.29
22.47
15.6
12.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
107
405
3.33
22.27
2.9
2.5
e6/l
0.7
0.9
0.18
69
221
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
171
859
2.88
21.44
4.0
2.9
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
20
0
+∞
21.04
4.2
0.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
39
8.00
20.66
6.6
3.4
%
52.6
57.7
0.83
29
39
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
26
8
34.87
20.48
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
26
8
34.87
20.48
1.1
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
42
85
5.46
20.25
1.7
2.5
g/l
1.2
1.4
0.64
35
77
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
25
7
38.21
20.10
3.5
3.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
116
486
3.04
20.07
3.1
2.2
e6/l
6.3
6.4
0.02
106
420
(3014148) Varicella zoster virus Ab [Titer] in Serum
29
41
7.60
19.79
1.0
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
338
2560
6.03
19.46
51.3
13.3
%
13.7
13.4
4.44
338
2521
(3002256) Pathology report gross observation
84
298
3.37
19.17
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
59
166
4.05
18.98
1.7
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
40
87
5.05
17.75
1.6
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
118
531
2.82
17.61
2.4
1.9
%
1.4
1.4
0.13
109
488
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
345
2716
7.10
17.47
37.3
9.4
ml/min/173m2
94.3
91.6
1.33
320
2188
(3030905) Polymorphonuclear cells [#/volume] in Blood
26
39
7.11
16.81
7.2
2.9
e9/l
3.6
4.2
0.53
26
39
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
16
0
+∞
16.80
4.1
0.0
mg/l
3.0
—
—
16
0
(40760892) CBC W Ordered Manual Differential panel - Blood
137
687
2.60
16.29
10.1
4.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
88
351
2.99
16.27
2.4
1.8
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
16
13
12.83
16.13
1.2
1.2
u/l
24.8
5.8
—
11
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
49
6.11
15.64
1.0
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
50
5.99
15.33
2.3
6.6
u/ml
0.2
0.3
1.49
13
30
(46235355) HIV 1 and 2 tests - Meaningful Use set
149
812
2.42
14.48
1.9
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
80
327
2.86
13.99
2.0
1.5
nmol/l
1247.6
1161.0
0.29
66
255
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
93
412
2.69
13.93
1.8
1.5
pmol/l
470.1
10899616.1
0.50
82
367
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
111
4.04
13.79
1.6
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
356
3153
10.32
13.62
33.5
9.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
152
871
2.29
12.81
1.7
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
236
2.91
11.68
2.4
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
69
4.48
11.50
2.7
2.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
61
241
2.84
11.23
2.4
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
58
225
2.88
11.03
11.0
15.2
inr
1.1
1.2
—
7
40
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
13
14
9.60
10.82
1.2
1.0
miu/ml
1363.3
1367.1
0.00
13
14
(3003396) Base excess in Arterial blood by calculation
58
228
2.84
10.76
15.4
9.2
mmol/l
-0.7
1.0
2.58
47
176
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
26
6.81
10.73
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
52
200
2.87
10.02
3.7
3.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
248
1838
2.12
9.80
5.3
3.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
342
2935
4.14
9.63
43.4
11.4
%
39.5
41.5
6.50
313
2435
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
124
729
2.07
9.18
1.4
1.3
u/ml
1.1
1.2
0.10
29
187
(3026493) Urate [Moles/volume] in Serum or Plasma
112
634
2.11
9.17
4.4
2.6
umol/l
344.1
6926.2
2.86
107
570
(3051651) Icteric interference index of Serum or Plasma
12
15
8.24
8.91
2.6
2.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
14
22
6.58
8.59
2.7
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
67
316
2.38
8.50
1.9
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
338
2923
3.45
8.47
6.7
3.8
mmol/l
4.6
4.8
2.27
332
2760
(1616796) Gas panel - Central venous blood
18
38
4.93
8.20
5.8
3.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
11
5
22.62
8.06
2.6
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
5
22.62
8.06
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
125
774
1.94
7.77
4.6
3.1
mmol/l
2.3
2.4
1.11
119
684
(3012501) Base excess in Blood by calculation
18
40
4.68
7.73
4.4
2.4
mmol/l
1.5
2.4
—
9
28
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
18
6.86
7.65
2.3
1.7
pg
31.5
33.7
0.89
12
18
(3035350) Ketones [Presence] in Urine by Test strip
188
1334
1.85
7.62
3.8
3.0
estimate
0.0
0.0
0.00
53
236
(3009261) Glucose [Presence] in Urine by Test strip
188
1352
1.81
7.13
3.9
3.1
estimate
0.0
0.0
0.50
55
229
(3021601) Nitrite [Presence] in Urine by Test strip
186
1334
1.81
7.11
5.5
4.3
estimate
0.0
0.0
0.00
54
241
(3003338) MCHC [Mass/volume]
320
2746
2.46
7.09
46.5
13.4
g/l
332.3
334.5
4.11
320
2734
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
11
9
12.56
6.62
1.8
1.7
umol/l
25.2
30.4
—
11
9
(3007930) Methemoglobin/Hemoglobin.total in Blood
24
76
3.31
6.42
6.5
6.4
%
0.9
0.9
0.13
24
68
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
15
6.83
6.34
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
5
18.41
6.29
1.9
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
31
116
2.83
6.26
1.7
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
62
3.53
6.24
2.2
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
39
4.25
6.15
5.7
2.6
%
14.0
16.5
—
8
23
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
98
603
1.86
6.00
2.5
2.2
mg/l
1.7
0.9
1.31
80
446
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
24
81
3.10
5.80
6.3
6.1
%
1.3
1.5
0.54
24
72
(3015736) pH of Urine
151
1065
1.72
5.77
2.9
2.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
97
610
1.81
5.48
2.4
2.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
29
113
2.70
5.45
1.5
1.3
—
1.5
—
0
7
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
5
0
+∞
5.22
1.4
0.0
mg/l
1.8
—
—
5
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
116
2.63
5.18
1.8
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
65
3.20
5.15
2.4
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
67
3.10
4.91
1.6
1.3
ug/g
222.9
323.7
1.13
15
39
(3020393) Adenovirus Ag [Presence] in Stool
7
5
14.24
4.59
1.1
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
92
598
1.72
4.56
2.9
3.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
21
4.87
4.56
1.3
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
118
2.49
4.52
1.5
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
15
44
3.51
4.51
7.3
7.9
mmol/l
107.5
105.3
1.19
15
36
(3039000) Anion gap in Blood
15
44
3.51
4.51
7.3
7.9
mmol/l
12.4
10.9
0.86
15
36
(4281824)
10
22
4.65
4.33
1.2
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
16
51
3.24
4.26
2.3
3.9
mg/l
30.7
29.6
—
9
45
(3034860) Kappa light chains.free [Mass/volume] in Serum
16
51
3.24
4.26
2.3
3.9
mg/l
38.5
47.9
—
9
46
(40768443) Skin Pathology biopsy report
23
91
2.63
4.22
1.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
27
4.17
4.19
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
277
2397
1.67
4.08
3.7
3.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
7
10.17
4.02
2.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
436
1.75
4.00
3.6
3.5
ng/l
23.5
320.3
2.39
48
289
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
48
3.22
3.97
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
48
3.22
3.97
1.5
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
110
780
1.59
3.81
4.0
2.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
96
2.49
3.81
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
45
3.20
3.69
1.6
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
41
3.25
3.53
1.6
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
31
3.63
3.51
1.5
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
96
675
1.58
3.41
4.4
3.3
estimate
0.0
0.0
0.50
53
234
(40760888) Immunoglobulin light chains.free panel - Serum
12
37
3.32
3.37
1.2
4.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
32
3.51
3.36
1.4
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
118
872
1.52
3.35
3.3
3.0
ng/l
22.7
42.7
0.54
69
481
(3008898) HLA-B27 [Presence]
30
154
2.03
3.10
1.2
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
12
5.92
3.03
1.7
2.0
%
206.9
132.6
—
7
12
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
134
1042
1.45
2.88
4.1
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
41
2.99
2.88
5.1
2.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
6
9
6.76
2.88
5.3
3.2
%
50.8
47.1
—
6
9
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
106
2.15
2.69
2.3
2.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
55
2.61
2.65
1.7
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
25
3.66
2.59
1.8
1.4
—
—
—
0
0
(3019225) pH of Specimen
36
210
1.79
2.58
4.5
4.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
11
5.52
2.55
1.7
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
69
2.38
2.52
2.3
2.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
26
3.52
2.50
1.1
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
26
3.52
2.50
1.1
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
16
4.44
2.48
2.0
3.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
131
1.98
2.47
1.2
1.4
miu/ml
256.7
260.9
0.02
11
65
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
509
1.52
2.45
2.2
3.2
ng/l
828.8
586.9
0.28
62
412
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
63
0.00
2.45
0.0
5.7
—
381.7
—
0
55
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
12
5.06
2.41
1.7
1.2
ug/l
13.4
9.0
—
6
12
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
59
2.43
2.32
1.7
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
66
2.33
2.27
1.9
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
317
2955
1.60
2.24
5.7
4.1
mmol/l
2.7
2.9
5.21
309
2779
(3004451) EKG impression Narrative
5
9
5.61
2.22
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
51
343
1.57
2.17
1.5
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
313
2915
1.55
2.15
5.6
3.8
mmol/l
1.5
1.4
4.37
308
2748
(42529406) Shigella sp [Presence] in Stool by Culture
20
102
2.02
2.15
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
283
0.47
2.06
4.1
5.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
81
611
1.42
1.98
2.9
3.3
mg/l
42.1
419.7
1.20
46
402
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
64
2.24
1.97
2.5
2.3
g/l
3.4
3.1
0.55
14
54
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
33
2.77
1.94
1.8
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
99
1.97
1.94
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
39
2.61
1.93
7.3
2.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
39
2.61
1.93
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
39
2.61
1.93
1.9
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
39
2.61
1.93
1.9
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
39
2.61
1.93
1.7
1.4
—
—
—
0
0
(3013512) EKG study
82
623
1.41
1.92
3.3
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
84
641
1.40
1.92
4.0
4.1
mg/mmol
5.9
10.5
0.89
53
424
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
42
610
0.65
1.91
2.8
3.5
%
21.2
21.7
0.07
11
214
(3014765) Yersinia sp identified in Stool by Organism specific culture
19
100
1.95
1.89
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
54
0.00
1.87
0.0
1.5
—
18.3
—
0
45
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
40
2.54
1.85
1.7
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
40
2.54
1.85
1.7
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
98
774
1.37
1.82
2.9
3.0
mmol/l
8.5
8.6
0.12
91
666
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
23
3.08
1.80
1.7
1.1
—
—
—
0
0
(44790049)
8
29
2.80
1.80
1.8
1.4
—
—
—
0
0
(44790047)
8
29
2.80
1.80
1.8
1.4
—
—
—
0
0
(44806118)
8
29
2.80
1.80
1.8
1.4
—
—
—
0
0
(44790048)
8
29
2.80
1.80
1.8
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
302
2820
1.43
1.76
5.0
3.4
mmol/l
1.2
1.3
3.35
295
2657
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
54
2.26
1.76
1.4
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
36
2.54
1.75
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
30
2.70
1.73
1.9
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
7
24
2.95
1.73
1.3
2.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
13
3.88
1.72
1.2
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
456
0.63
1.67
2.4
2.5
ug/l
0.9
0.7
0.27
15
231
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
19
3.19
1.67
3.2
3.2
u/ml
564.2
660.7
—
6
19
(4268621)
10
43
2.36
1.61
2.6
2.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
30
192
1.61
1.60
2.2
2.3
e9/l
3.9
4.2
0.25
24
166
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
26
2.72
1.59
1.7
3.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
20
3.03
1.58
1.8
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
44
2.31
1.54
1.6
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
15
3.36
1.53
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
72
1.98
1.51
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
72
1.98
1.51
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
28
2.53
1.46
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
46
2.21
1.41
1.1
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
7
29
2.44
1.40
1.9
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
1.2
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
23
2.63
1.37
2.8
2.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
23
2.63
1.37
2.8
2.8
mmol/l
4.1
4.0
—
6
23
(3035285) Chloride [Moles/volume] in Venous blood
6
23
2.63
1.37
2.8
2.8
mmol/l
106.0
105.9
—
6
23
(3019060) Gas panel - Arterial blood
21
128
1.68
1.36
5.5
5.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
9
42
2.17
1.34
6.4
2.9
mmol/l
1.3
1.5
—
9
42
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
256
0.57
1.34
2.1
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
18
2.80
1.29
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
18
2.80
1.29
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
189
0.52
1.26
3.1
3.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
14
78
1.83
1.23
1.5
1.2
—
3.2
—
0
9
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
5
19
2.65
1.22
1.0
1.4
—
8.6
—
0
7
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
592
0.73
1.21
1.8
2.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
26
2.33
1.19
1.0
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
42
310
1.40
1.19
1.5
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
20
126
1.62
1.17
3.0
2.7
ng/l
84.8
109.0
0.30
20
111
(3037756) Immunofixation for Serum or Plasma
8
39
2.07
1.16
1.9
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
25
167
1.53
1.16
5.2
3.8
mmol/l
-0.1
1.3
0.60
15
128
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
65
1.88
1.14
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
88
1.74
1.13
2.1
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
49
627
0.75
1.10
5.2
3.0
kg/l
1.0
1.0
—
9
77
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
21
2.40
1.09
2.8
2.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
32
2.21
1.08
1.1
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
646
0.75
1.07
1.8
2.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
124
0.48
1.07
1.2
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
82
1.74
1.06
1.9
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
47
1.94
1.03
2.2
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
10
53
1.91
1.02
3.0
2.2
ug/min
70.7
136.6
—
5
34
(1002224) Polysomnography panel
10
175
0.56
1.01
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
25
173
1.48
1.00
5.2
3.7
ph
7.4
7.4
—
7
20
(3019832) Treponema pallidum Ab [Presence] in Serum
35
462
0.73
0.97
1.8
1.8
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
36
1.96
0.97
7.7
3.2
mmol/l
8.0
7.5
—
7
36
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
324
0.69
0.94
1.8
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
63
1.77
0.91
1.4
1.2
—
1.0
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
29
2.09
0.89
1.0
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
29
2.09
0.89
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
29
2.09
0.89
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
29
2.09
0.89
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
317
0.71
0.84
2.0
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
17
114
1.52
0.81
1.7
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
99
1.54
0.77
4.1
3.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
53
1.72
0.76
8.6
5.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
219
0.67
0.75
1.4
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
26
1.94
0.71
1.8
8.3
%
6.7
13.0
—
5
26
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
58
1.57
0.70
1.2
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
58
1.57
0.70
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
27
1.86
0.68
1.8
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
12
179
0.66
0.68
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
279
0.74
0.64
1.1
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
209
1.32
0.62
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
30
1.68
0.61
2.2
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
40
483
0.81
0.60
1.3
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
1.1
—
0
11
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
273
2624
1.17
0.59
4.7
4.3
mu/l
2.0
2.3
0.28
257
2448
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
229
2174
1.15
0.59
4.3
3.6
pmol/l
14.5
14.5
0.16
210
2010
(1617658) Protocol used for examination of sentinel lymph nodes
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
33
266
1.26
0.58
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
55
1.46
0.56
6.1
3.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
125
0.63
0.55
1.6
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
17
125
1.38
0.54
1.6
1.5
u/l
5.4
8.3
0.98
11
104
(3001019) Free T4 and TSH panel - Serum or Plasma
24
187
1.30
0.54
1.4
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
20
154
1.32
0.49
4.2
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
46
1.53
0.48
1.1
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
46
1.53
0.48
10.4
5.6
%
46.6
66.0
—
7
46
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
210
0.75
0.47
1.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
276
0.78
0.47
1.3
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
116
1256
0.89
0.47
4.0
2.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
118
0.67
0.46
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
118
0.67
0.46
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
119
0.66
0.46
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
119
0.66
0.46
1.5
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
49
1.44
0.46
1.3
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
60
1.34
0.40
1.3
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
105
0.66
0.40
2.0
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
258
0.80
0.39
1.4
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
23
277
0.82
0.37
1.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
23
277
0.82
0.37
1.3
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
49
435
1.15
0.35
1.6
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
23
274
0.83
0.33
1.3
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
411
0.86
0.33
1.2
1.6
—
—
—
0
0
(4010399)
15
187
0.79
0.33
1.3
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
97
0.72
0.31
1.9
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
53
1.33
0.31
1.4
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
54
1.30
0.30
1.1
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
54
490
1.12
0.29
1.2
1.3
iu/ml
20.1
23.6
0.17
15
150
(3050129) First trimester maternal screen panel - Serum or Plasma
11
140
0.78
0.28
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
94
1.29
0.28
1.3
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
72
0.69
0.26
1.0
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
82
0.73
0.24
1.0
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
24.4
—
0
11
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
66
0.75
0.17
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
51
479
1.08
0.15
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
98
0.81
0.14
1.5
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
188
0.90
0.11
1.3
2.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
167
0.89
0.11
1.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
44
1.14
0.10
5.6
1.8
%
13.5
12.9
—
5
44
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
278
2756
1.04
0.08
3.7
3.7
mmol/l
5.8
5.8
0.14
267
2570
(4094501)
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
92
0.87
0.07
1.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
94
0.85
0.07
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
95
0.84
0.06
1.5
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
259
2571
1.03
0.06
6.3
4.6
mmol/mol
37.1
38.5
1.40
251
2438
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
170
1.06
0.04
2.2
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
101
1.09
0.04
1.3
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
78
766
1.02
0.04
1.7
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
232
1.04
0.02
1.0
1.3
iu/ml
61.6
174.0
—
7
97
(3045414) Leukocytes [Presence] in Urine
12
114
1.05
0.00
1.4
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
129
1.01
0.00
3.6
3.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
48
484
0.99
0.00
1.3
1.3
u/ml
1.3
6.5
2.34
16
190
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
5
0.00
0.00
0.0
1.6
—
85.8
—
0
5
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
69
0.87
0.00
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
89
1.01
0.00
1.3
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
49
1.02
0.00
1.0
1.5
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
9
90
1.00
0.00
7.1
7.9
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
5
0.00
0.00
0.0
3.4
—
132.8
—
0
5
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
2.4
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
75
0.93
0.00
2.9
1.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
50
1.00
0.00
1.4
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
9
0.00
0.00
0.0
8.9
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
57.3
—
0
5
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
16.9
—
0
7
(4038314)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
105.5
—
0
6
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4306422)
5
53
0.94
0.00
1.2
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
3.8
—
0
7
(3036670) Protein [Mass/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
43.8
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint K11_IBD_STRICT_PSC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have K11_IBD_STRICT_PSC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: K11_IBD_STRICT_PSC – IBD (strict) with PSC
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data